Clinical outcomes and safety profile of emicizumab and other treatment options for the management of children and adults with severe haemophilia A in the UAE: A retrospective study at two tertiary hospitals
By:
Authors
Laila Alkhouli
Pediatric Institute, Cleveland Clinic Foundation, Cleveland, United States
Haytham Al Jabour
Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
Hani Yousif Osman
Tawam Hospital, Al Ain, United Arab Emirates
Muhammad Ibraham Khanani
Burjeel Royal Hospital, Asharej, Al Ain, United Arab Emirates
Muhammad Faisal Khanani
Tawam Hospital, Al Ain, United Arab Emirates
Nasser Al Azein
Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates
DOI: https://doi.org/10.2478/jhp-2025-0013 | Journal eISSN: 2055-3390
Language: English
Page range: 104 - 110
Published on: Oct 1, 2025
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Related subjects:
© 2025 Haydar Al Rufaye, Laila Alkhouli, Haytham Al Jabour, Hani Yousif Osman, Muhammad Ibraham Khanani, Muhammad Faisal Khanani, Nasser Al Azein, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.